SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-18-041541
Filing Date
2018-02-13
Accepted
2018-02-13 10:06:03
Documents
2
Group Members
COLUMBIA ACORN FUND

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d481071dsc13ga.htm SC 13G/A 47277
2 EX-99.1 d481071dex991.htm EX-99.1 4176
  Complete submission text file 0001193125-18-041541.txt   53582
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 18600382
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 312-634-9200
COLUMBIA WANGER ASSET MANAGEMENT LLC (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 043519872 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000